What Long-Term Investors Should Know About This Hims Insider Filing
This tax-related withholding was tied to quarterly RSU vesting, not discretionary selling.
Overview
Chief Operating Officer Michael Chi disposed of 47,702 shares of Hims & Hers Health, Inc. (NYSE:HIMS) on August 14, according to an SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($28.15); post-transaction value based on the August 14 market close ($28.15).
Details
Hims & Hers Health operates as a leading digital health platform with a $6.4 billion market capitalization and $2.6 billion in TTM revenue, positioning itself at the intersection of telehealth and direct-to-consumer pharmaceutical distribution. The company's integrated platform model creates competitive advantages through operational efficiency, customer convenience, and data-driven personalization. Despite current net losses of $142.0 million TTM, the company's substantial revenue base and market scale reflect strong consumer adoption of its digital-first healthcare delivery model.
Source
Originally published at www.fool.com.